The unanimous C-suite insider buying cluster at a low-float micro-cap is a strong contrarian bullish signal. Per academic literature, cluster buys from top executives at small-cap biotechs are among the most predictive insider patterns, often preceding positive pipeline catalysts or near-term value events. Monitor for upcoming clinical data readouts, regulatory updates, or financing news that may have motivated this synchronized buying. The stock's low dollar-purchase size ($30K) but high proportional signal (~0.4% of cap) suggests insiders view current ~$3/share as a favorable entry point ahead of a catalyst.
Price Chart
Executive Summary
Six PCSA insiders, including the CEO, CFO, and four other C-suite officers, made clustered open-market purchases totaling ~$30K at $2.97/share on April 15, 2026. This is a unanimous insider-buying cluster at a micro-cap ($8M market cap) clinical-stage biotech, representing ~0.4% of market cap — a notable signal when all senior insiders voluntarily commit cash in concert.
Key Financial Metrics
Key Facts
- Six insiders bought a total of ~10,100 shares at $2.97, aggregate $30K.
- CFO, CEO, Pres. R&D, CAO, Chief Business Strategy Officer, and Chief Development Officer all bought on the same day.
- Total insider cluster value represents ~0.4% of PCSA's $8M market cap.
- No open-market sales detected in the cluster — all buys.
- All trades are open-market purchases (code P), not option exercises or grants.
- Recent 30-day insider activity showed 6 buys totaling $31K — this cluster accounts for the bulk.
Financial Impact
$30K in open-market insider purchases, ~0.4% of PCSA's $8M market cap.
Risk Factors
- Clinical-stage biotech with $8M market cap carries inherent binary risk — pipeline failure could wipe out equity.
- Insider purchases at this scale ($30K) are modest in absolute dollars; insiders at micro-caps often make small token buys.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PCSA-1779226326165 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | EFFECT | $1.81 | awaiting T+5 | — | $1.79 (+0.83%) |
Oct 22, 2026 4d ago | DEF 14A | $1.81 | awaiting T+5 | — | $1.79 (−0.83%) |
Oct 9, 2026 17d ago | S-3 | $1.90 $1.73 | ▲ +8.95% | ▲ +7.45% | $1.79 (+5.53%) |
Jul 29, 2026 12w ago | 8-K | $2.03 $2.19 | ▲ +7.88% | ▲ +2.35% | $1.79 (−11.58%) |
Jul 1, 2026 16w ago | Insider Cluster | $2.16 $2.16 | · 0.00% | ▼ −1.37% | $1.79 (−16.90%) |
Jun 16, 2026 18w ago | Insider Cluster | $2.15 $1.93 | ▼ −10.23% | ▼ −9.19% | $1.79 (−16.51%) |
Jun 16, 2026 18w ago | Insider Cluster | $2.15 $1.93 | ▼ −10.23% | ▼ −9.19% | $1.79 (−16.51%) |
Jun 1, 2026 21w ago | Insider Cluster | $2.92 $2.04 | ▼ −30.31% | ▼ −27.34% | $1.79 (−38.53%) |
May 19, 2026 22w ago | Insider Cluster | $2.61 $2.64 | ▲ +1.15% | ▼ −0.65% | $1.79 (−31.23%) |
May 19, 2026 22w ago | Insider Cluster | $2.61 $2.64 | ▲ +1.15% | ▼ −0.65% | $1.79 (−31.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers